<code id='79B082021E'></code><style id='79B082021E'></style>
    • <acronym id='79B082021E'></acronym>
      <center id='79B082021E'><center id='79B082021E'><tfoot id='79B082021E'></tfoot></center><abbr id='79B082021E'><dir id='79B082021E'><tfoot id='79B082021E'></tfoot><noframes id='79B082021E'>

    • <optgroup id='79B082021E'><strike id='79B082021E'><sup id='79B082021E'></sup></strike><code id='79B082021E'></code></optgroup>
        1. <b id='79B082021E'><label id='79B082021E'><select id='79B082021E'><dt id='79B082021E'><span id='79B082021E'></span></dt></select></label></b><u id='79B082021E'></u>
          <i id='79B082021E'><strike id='79B082021E'><tt id='79B082021E'><pre id='79B082021E'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:knowledge    Page View:853
          King Street Properties’ Pathway Devens campus. -- biotech coverage from STAT
          Pat Greenhouse/Globe Staff

          MORRISVILLE, N.C. — Ten minutes from the Raleigh airport, the future of biotech is under construction.

          On either side of a new stretch of four-lane highway sit two $1 billion biomanufacturing campuses, which will bring a combined 2.5 million square feet of research and development and advanced manufacturing space to a region that has become the No. 1 place where North America makes prescription drugs.

          advertisement

          One campus, called Pathway Triangle, is being built by a developer from Boston, King Street Properties. King Street — which has projects in Cambridge, Waltham, Allston, and Lexington — is building a similarly vast biomanufacturing campus in Devens. But these days it also sees a land of opportunity 700 miles to the south, in North Carolina.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more
          Readout Newsletter: PTC, Dyne, Rapport, Cytokinetics news
          Readout Newsletter: PTC, Dyne, Rapport, Cytokinetics news

          MattRourke/APWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsle

          read more
          Supreme Court strikes down use of affirmative action
          Supreme Court strikes down use of affirmative action

          ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

          read more

          Lab trade group sues FDA to halt regulation of lab

          Thesuit,filedinaTexasfederalcourtbytheAmericanClinicalLaboratoryAssociationandPCRlabHealthTrackRx,cl